Re: Roberto Contieri, Marco Paciotti, Alessandro Uleri, et al. Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe Trial. Eur Urol Oncol 2026;9:404-12 [0.03%]
Roberto Contieri、Marco Paciotti、Alessandro Uleri等。在HuNIRe前瞻性试验中，选择性T1期非肌层浸润性膀胱癌患者可以安全地省略第二次经尿道膀胱肿瘤电切术：第二例非肌层浸润性膀胱癌的经尿道膀胱肿瘤切除术可以在选定的T1期非肌层浸润性膀胱癌患者中省略：来自前瞻性HuNIRe试验的结果。 Eur Urol Oncol 2026;9:404-12
Francesco Di Bello,Andrea Gallioli,Joan Palou et al.
Francesco Di Bello et al.
Reply to Simone Sforza's Letter to the Editor re: Mehdi Kardoust Parizi, David D'Andrea, Benjamin Pradere, et al. Prognostic Factors for Recurrence and Survival After Radical Cystectomy for Non-muscle-invasive Bladder Cancer: A Multicenter Analysis of 1032 Patients. In press. http://dx.doi.org/10.1016/j.euo.2026.06.001 [0.03%]
Simone Sforza来信评论有关Mehdi Kardoust Parizi等人的文章“非肌层浸润性膀胱癌根治术后复发和生存的预后因素：1032例患者的多中心分析”答复
Mehdi Kardoust Parizi,Shahrokh F Shariat
Mehdi Kardoust Parizi
Re: Contieri R, Paciotti M, Uleri A, et al. Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe Trial. Eur Urol Oncol. 2026;9:404-412 [0.03%]
Contieri R，Paciotti M，Uleri A等。T1非肌层浸润性膀胱癌患者：前瞻性HuNIRe研究结果。Eur Urol Oncol. 2026;9:404-412
Roberto Mario Scarpa
Roberto Mario Scarpa
Reply to Pietro Scilipoti, Giuseppe Rosiello, Andrea Salonia, Alberto Briganti, Marco Moschini, Francesco Montorsi Letter to the Editor re: Roberto Contieri, Marco Paciotti, Alessandro Uleri, et al. Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Pros [0.03%]
Pietro Scilipoti等《致客编来信》对Roberto Contieri等《选择性T1期非肌层浸润性膀胱癌患者可以省去第2次经尿道膀胱肿瘤切除术：来自Prospective Bladder Tumor项目的结果》的回复
Roberto Contieri,Rodolfo Hurle
Roberto Contieri
Efficacy of Olaparib Plus Abiraterone for Patients with Metastatic Castration-resistant Prostate Cancer and Single Homologous Recombination Repair Gene Mutations in PROpel [0.03%]
PROpel研究：奥拉帕利联合阿比特龙治疗伴单一同源重组修复基因突变的转移性去势抵抗性前列腺癌患者的疗效分析
Neal Shore,Noel W Clarke,Andrew J Armstrong et al.
Neal Shore et al.
PROpel (phase 3 randomized [1:1], double-blind trial: NCT03732820) met its primary endpoint, showing statistically significantly improved investigator-assessed radiographic progression-free survival (rPFS) with olaparib plus abiraterone ver...
Re: Contieri R, Paciotti M, Uleri A, et al. Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe Trial. Eur Urol Oncol 2026;9:404-412 [0.03%]
Contieri R, Paciotti M, Uleri A等。HuNIRe研究结果：选择性T1期非肌层浸润性膀胱癌患者可以安全地省略第二次经尿道膀胱肿瘤电切术。Eur Urol Oncol 2026;9:404-412
Pietro Scilipoti,Giuseppe Rosiello,Andrea Salonia et al.
Pietro Scilipoti et al.
Natural History, Tumor Growth Kinetics, and Renal Functional Outcomes of Sporadic Bilateral Multifocal Papillary Renal Cell Carcinoma: A 25-yr Prospective Cohort Study [0.03%]
散发性双侧多灶性乳头状肾细胞癌的自然史、肿瘤生长动力学和肾脏功能结局：一项前瞻性队列研究（随访25年）
Hangcheng Fu,Ruben Blachman-Braun,Lauren Loebach et al.
Hangcheng Fu et al.
Background and objective: Bilateral or multifocal (BMF) papillary renal cell carcinoma (pRCC) arising without a confirmed pathogenic germline variant represents a clinically distinct entity with a poorly defined natural h...
Saline-assisted Fascial Exposure Microultrasound-guided Nerve Preservation During Robotic Prostatectomy: Interim Analysis of a Randomized Controlled Trial [0.03%]
机器人辅助前列腺癌根治术盐水冲刷筋膜暴露组与超声刀组的神经保护效果：一项随机对照试验的中期分析
Adriana M Pedraza,Monali Fatterpekar,Himanshu Joshi et al.
Adriana M Pedraza et al.
Background: Erectile dysfunction remains a major morbidity after radical prostatectomy. The SAFE technique uses real-time, micro-ultrasound-guided low-pressure hydrodissection to enable atraumatic nerve sparing. ...
Prognostic Factors After Radical Cystectomy for Non-muscle-invasive Bladder Cancer: From Prognostication to Patient Selection [0.03%]
根治性膀胱切除术后非肌层浸润性膀胱癌的预后因素：从预后判断到患者选择
Simone Sforza,Felix Lübbersmeyer,Andrea Mari
Simone Sforza
Detection and Localization of Unfavorable-histology Prostate Cancer Using MRI and Whole-mount Histopathology [0.03%]
基于MRI和整块组织病理学的不利病史前列腺癌的检测与定位
Mariluz Rojo Domingo,Anna Dornisch,Christopher C Conlin et al.
Mariluz Rojo Domingo et al.
Background and objective: Detecting localized prostate cancer (PC) with metastatic potential-defined as unfavorable-histology PC (uhPC), comprising Grade Group (GG) ≥3 disease or GG 2 disease with cribriform/intraductal ...